Foundayo

Weight-management medicine: Foundayo savings-card, separate self-pay, LillyDirect and qualified Medicare Bridge contacts.

Product / program source ↗ · Checked 2026-10-23

FDA approved Foundayo for adult chronic weight management on April 1, 2026. Commercial savings and self-pay terms are distinct; do not apply the commercial government-insurance exclusion to every self-pay option. Current card terms end December 31, 2026 and may change. Foundayo is absent from the current Lilly Cares product list; no charitable-PAP eligibility or price guarantee is established.

Eli Lilly medicine support and savings

provider services

Lilly — medicine questions and safety reporting

Official page read

Phone800-545-5979

General U.S. Lilly medicine questions; product/device adverse-experience reporting is directed by the same official contact page.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

This general manufacturer route is not Foundayo-specific financial assistance intake. Hours for Foundayo are not established here.

View source ↗ · Source checked 2026-10-23

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

patient assistance

Foundayo — commercial savings-card questions

Official page read

Phone866-923-1953

Published savings-card program contact, including eligibility-change notification and obtaining a post-transaction reimbursement form.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Commercial card requires the current approved-use, commercial-insurance, age/residency and other terms; government beneficiaries are excluded. This is not Lilly Cares, charitable intake or guaranteed reimbursement. Current terms end December 31, 2026; recheck before use.

View source ↗ · Source checked 2026-10-23

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

patient assistance

Foundayo — separate self-pay savings-card questions

Official page read

Phone866-923-1953

Contact published in this product's self-pay savings-card terms for a copy of the reimbursement form.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Foundayo self-pay card is distinct from its commercial-insurance card. Cash payment, no insurance reimbursement and no deductible/out-of-pocket credit conditions apply. Do not blanket-apply the commercial card's government-insurance exclusion to this separate self-pay option. Current terms end December 31, 2026 and may change.

View source ↗ · Source checked 2026-10-23

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

patient assistance

Foundayo — savings-card post-transaction reimbursement correspondence

Official page read

Phone

No phone listed for this route

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Savings Card Post-Transaction Reimbursement PO Box 42638 Cincinnati, OH 45242 Attn: PTR Processing

Completed savings-card post-transaction reimbursement claim form, under this product's current card terms only. Not prescriptions, PAP applications or general medical records.

The current terms require an activated eligible card, pharmacy receipt and other claim information. Current 2026 terms give a March 31, 2027 submission deadline; reimbursement is not guaranteed. Confirm current instructions before mailing.

View source ↗ · Source checked 2026-10-23

Report an update

LillyDirect Pharmacy, LLC

pharmacy help desk

LillyDirect Pharmacy — support and prescribing-system location

Official page read

Phone844-559-3471

LillyDirect pharmacy support. Current Zepbound delivery page explicitly publishes this number for refills, self-pay journey and medicine questions; NPPES corroborates the pharmacy phone.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

LillyDirect Pharmacy, LLC 1555 S Harding St, Ste 171-B68 Indianapolis, IN 46221-1873

NPPES registered MAILING address only; mailed prescription or program application acceptance is not established.

Physical address

1555 S Harding St, Ste 171-B68 Indianapolis, IN 46221-1873

NPI 1912889320/NCPDP 1574056 prescribing-system location published for Foundayo and Zepbound; not a verified walk-in service.

Foundayo and Zepbound current pages identify the same pharmacy/NPI. Fulfillment partners and payment/formulation eligibility differ. No charitable-PAP association, price guarantee, pharmacy fax or email is inferred.

View source ↗ · Source checked 2026-10-23 · Source revision NPPES last updated March 23, 2026; Zepbound page CMAT-05333 08/2026. · Foundayo current delivery page, same prescribing pharmacy ↗ · NPPES pharmacy identity, phone and registered location/mailing address ↗

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

Medicare GLP-1 Bridge — CMS

patient assistance

Medicare GLP-1 Bridge — beneficiary questions

Official page read

Phone800-633-4227

1-800-MEDICARE for beneficiary Bridge questions and program information.

TTY phone877-486-2048

TTY access to Medicare for beneficiary Bridge information; not an ordinary voice or fax line.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Current Medicare beneficiary eligibility and formulation page ↗

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

pharmacy prior auth

Medicare GLP-1 Bridge — prescriber prior-authorization support

Official page read

Phone855-273-0102

Prescriber questions about Bridge prior authorization process or request status.

Published hours

Monday–Friday 08:00–19:00 Eastern.

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

View source ↗ · Source checked 2026-10-23 · Source revision Provider page last modified August 6, 2026.

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

fax prior auth

Medicare GLP-1 Bridge — clinician prior-authorization fax

Official page read

Phone

No phone listed for this route

Fax

800-530-2404

Completed Bridge prior-authorization request from the prescribing clinician under the current CMS form.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

A denied pharmacy claim submitted to the Bridge BIN/PCN is required BEFORE the prescriber submits this request; this is not a requirement for a prior Part D denial. Form submission is restricted to prescribing clinicians. Conditions eligible for regular Part D coverage follow that plan's process. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Current provider-page-linked CMS PA form, byte-identical to short URL ↗ · Current prescriber process and denial distinction ↗

Report an update

pharmacy help desk

Medicare GLP-1 Bridge — pharmacy claims help desk

Official page read

Phone844-673-0910

Pharmacy questions about Bridge claim submission or submitted-claim status.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

View source ↗ · Source checked 2026-10-23 · Source revision Pharmacy page last modified August 17, 2026.

Report an update

Wait time: not establishedBest time from caller reports: not established. Published hours are not a wait forecast.

email other

Medicare GLP-1 Bridge — technical program questions only

Official page read

Phone

No phone listed for this route

Published email

glp1demo@cms.hhs.gov

Technical questions about the CMS demonstration; do not include personally identifiable information or protected health information.

Published hours

Not published in this record

Product, plan and location

Confirm the exact product or service
National contact — confirm product and location

Mailing address

Not researched for this route

Not a patient case, prescription, PAP or prior-authorization submission inbox. If secure transfer is necessary, follow CMS instructions to arrange it. Temporary Medicare GLP-1 Bridge demonstration, July 1, 2026–December 31, 2027. Only eligible Part D beneficiaries and the current named formulations qualify: Foundayo tablets, Wegovy injection/HD/tablets and Zepbound KwikPen; single-dose Zepbound pens/vials excluded. Separate from commercial cards, manufacturer PAP and IRA negotiated-price rules. Eligibility and coverage must be confirmed; no price guarantee.

View source ↗ · Source checked 2026-10-23 · Source revision Provider page last modified August 6, 2026.

Report an update

For healthcare offices

Found the contact. Still need to make the call?

Explore how DialClerk organizes the brief, hold time and staff handoff for your next administrative call.

For the people making the calls

Put payer follow-up
on your office’s worklist.

Explore DialClerk for queued calls, hold handling, staff handoffs and a record of the next step. Tell us how your team works.

A request does not create an account or start a call. Use business contact information only. No patient information.

Foundayo

Eli Lilly medicine support and savings

LillyDirect Pharmacy, LLC

Medicare GLP-1 Bridge — CMS

Found the contact. Still need to make the call?

Put payer follow-upon your office’s worklist.

See how it could work for your practice

Put payer follow-up
on your office’s worklist.